Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CinCor Pharma, Inc. - Common Stock
(NQ:
CINC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 23, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
29.16 (3)
Ask (Size)
29.25 (9)
Prev. Close
29.06
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
43,764,323
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
February 21, 2023
From
CinCor Pharma Inc
Via
GlobeNewswire
There's a Lot to Love About Mineralys' Valentine's Day IPO
February 13, 2023
MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million
Via
MarketBeat
Topics
Initial Public Offering
Performance
More News
Read More
These 2 Healthcare Stocks Have Doubled in 2023
February 01, 2023
Via
MarketBeat
CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
January 24, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Where CinCor Pharma Stands With Analysts
↗
January 12, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 20, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why These Two Biotech Stocks Blasted Higher This Week
↗
January 13, 2023
Via
The Motley Fool
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
↗
January 13, 2023
Via
Investor's Business Daily
CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
January 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout
↗
January 10, 2023
Via
Investor's Business Daily
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
↗
January 09, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
January 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
January 09, 2023
Via
Benzinga
Stocks Building Off Of Friday's Rally
↗
January 09, 2023
Via
Talk Markets
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
↗
January 09, 2023
Via
Benzinga
CinCor Pharma (NASDAQ: CINC) Enters Into Agreement to be Acquired by AstraZeneca (NASDAQ: AZN) for $1.3 Billion
January 09, 2023
Via
Spotlight Growth
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
↗
January 09, 2023
Via
Investor's Business Daily
Why Is CinCor (CINC) Stock Up 138% Today?
↗
January 09, 2023
Via
InvestorPlace
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
↗
January 09, 2023
Via
Benzinga
US Stocks Open Higher; Dow Rises 150 Points
↗
January 09, 2023
Via
Benzinga
CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders
January 09, 2023
From
Halper Sadeh LLC
Via
Business Wire
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
↗
January 09, 2023
Via
Benzinga
AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline
↗
January 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
January 09, 2023
Via
Benzinga
Frequently Asked Questions
Is CinCor Pharma, Inc. - Common Stock publicly traded?
Yes, CinCor Pharma, Inc. - Common Stock is publicly traded.
What exchange does CinCor Pharma, Inc. - Common Stock trade on?
CinCor Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CinCor Pharma, Inc. - Common Stock?
The ticker symbol for CinCor Pharma, Inc. - Common Stock is CINC on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today